Shortages and big price tags have driven patients to unconventional sources of GLP-1 drugs In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist. He said, “Hey ...
A Democratic congresswoman is imploring President Donald Trump’s newly Senate-confirmed White House drug czar to follow the science and proactively support fully legalizing marijuana—going beyond the ...
Hosted on MSN
The Latest Science About GLP-1 Drugs & Weight Loss
Name brand GLP-1 drugs like Ozempic and Wegovy have quickly become household names, akin to Tylenol or Advil, and their rise in popularity is only increasing. Originally developed to treat Type 2 ...
The high-profile semaglutide drugs Ozempic and Wegovy have changed how millions of adults manage type 2 diabetes and weight, respectively. Now many thousands of teenagers are being prescribed ...
In December 2017, the FDA approved a new injectable drug to treat type 2 diabetes called semaglutide, which you likely know by its brand name: Ozempic. A few years later, during the pandemic, Wegovy, ...
In the past 3 years, illicit fentanyl killed nearly 250,000 people in the US, according to the US Centers for Disease Control and Prevention (CDC). The estimated number of overdose deaths in the US ...
Seventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys. Infusions of the drug gave her ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained ...
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved. When you purchase through links on our site, we ...
PHILADELPHIA — When Justin Carlyle, 23, began experimenting with drugs a decade ago, he found himself part of a generation of young Americans caught in the devastating wave of harm caused by fentanyl ...
No one knows better than Sarah Louise Butler what it means to encounter a drug shortage. Butler was diagnosed with rheumatoid arthritis, a painful autoimmune disease, in her 20s. She describes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results